Literature DB >> 16511373

Lessons from fragile X regarding neurobiology, autism, and neurodegeneration.

Randi J Hagerman1.   

Abstract

The fragile X mental retardation 1 gene (FMR1) mutation causes two disorders: fragile X syndrome (FXS) in those with the full mutation and the fragile X-associated tremor/ataxia syndrome (FXTAS) in some older individuals with the premutation. FXS is caused by a deficiency of the FMR1 protein (FMRP) leading to dysregulation of many genes that create a phenotype with ADHD, anxiety, and autism. FXTAS is caused by the elevation of FMR1-mRNA to levels 2 to 8 times normal in the premutation. This causes an RNA gain of function toxicity leading to brain atrophy, white matter disease, neuronal and astrocytic inclusion formation, and subsequent ataxia, intention tremor, peripheral neuropathy, and cognitive decline. The neurobiology and pathophysiology of FXS and FXTAS are described in detail.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16511373     DOI: 10.1097/00004703-200602000-00012

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  73 in total

Review 1.  Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models.

Authors:  Moushami Mallik; Subhash C Lakhotia
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

2.  Identification of expanded alleles of the FMR1 gene among high-risk population in Indonesia by using blood spot screening.

Authors:  Tri Indah Winarni; Agustini Utari; Farmaditya E P Mundhofir; Tzuhan Tong; Blythe Durbin-Johnson; Sultana M H Faradz; Flora Tassone
Journal:  Genet Test Mol Biomarkers       Date:  2011-10-11

Review 3.  Potential therapeutic interventions for fragile X syndrome.

Authors:  Josien Levenga; Femke M S de Vrij; Ben A Oostra; Rob Willemsen
Journal:  Trends Mol Med       Date:  2010-09-21       Impact factor: 11.951

Review 4.  The impact of FMR1 gene mutations on human reproduction and development: a systematic review.

Authors:  Vincenzo Noto; Conor Harrity; David Walsh; Kevin Marron
Journal:  J Assist Reprod Genet       Date:  2016-07-18       Impact factor: 3.412

5.  Potential Involvement of Impaired BKCa Channel Function in Sensory Defensiveness and Some Behavioral Disturbances Induced by Unfamiliar Environment in a Mouse Model of Fragile X Syndrome.

Authors:  Maria Isabel Carreno-Munoz; Fabienne Martins; Maria Carmen Medrano; Elisabetta Aloisi; Susanna Pietropaolo; Corentin Dechaud; Enejda Subashi; Guillaume Bony; Melanie Ginger; Abdelmalik Moujahid; Andreas Frick; Xavier Leinekugel
Journal:  Neuropsychopharmacology       Date:  2017-07-19       Impact factor: 7.853

6.  Fragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administration.

Authors:  Laura N Smith; Jakub P Jedynak; Miles R Fontenot; Carly F Hale; Karen C Dietz; Makoto Taniguchi; Feba S Thomas; Benjamin C Zirlin; Shari G Birnbaum; Kimberly M Huber; Mark J Thomas; Christopher W Cowan
Journal:  Neuron       Date:  2014-05-07       Impact factor: 17.173

Review 7.  Lithium: a promising treatment for fragile X syndrome.

Authors:  Zhonghua Liu; Carolyn Beebe Smith
Journal:  ACS Chem Neurosci       Date:  2014-05-15       Impact factor: 4.418

8.  Screening for intermediate CGG alleles of FMR1 gene in male Iranian patients with Parkinsonism.

Authors:  Atefeh Entezari; Mahmoud Shekari Khaniani; Tayyeb Bahrami; Sima Mansoori Derakhshan; Hossein Darvish
Journal:  Neurol Sci       Date:  2016-10-01       Impact factor: 3.307

9.  Progressive spatial processing deficits in a mouse model of the fragile X premutation.

Authors:  Michael R Hunsaker; H Jürgen Wenzel; Rob Willemsen; Robert F Berman
Journal:  Behav Neurosci       Date:  2009-12       Impact factor: 1.912

10.  Imitation in fragile X syndrome. Implications for autism.

Authors:  Marta Macedoni-Luksic; Laura Greiss-Hess; Sally J Rogers; David Gosar; Kerrie Lemons-Chitwood; Randi Hagerman
Journal:  Autism       Date:  2009-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.